Literature DB >> 22943430

Large-cell neuroendocrine carcinoma with epidermal growth factor receptor mutation: possible transformation of lung adenocarcinoma.

Satoru Yanagisawa1, Naoto Morikawa, Yuichiro Kimura, Yoko Nagano, Kazuhiro Murakami, Toshiharu Tabata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22943430     DOI： 10.1111/j.1440-1843.2012.02258.x

Source DB:  PubMed          Journal:  Respirology        ISSN： 1323-7799            Impact factor:   6.424


× No keyword cloud information.
  15 in total

Review 1.  Treatment of lung large cell neuroendocrine carcinoma.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-03-04

2.  A marked response to icotinib in a patient with large cell neuroendocrine carcinoma harboring an EGFR mutation: A case report.

Authors:  Yuehong Wang; Yi Hong Shen; Shanni Ma; Jianying Zhou
Journal:  Oncol Lett       Date:  2015-06-22       Impact factor: 2.967

3.  Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer.

Authors:  Jeong Uk Lim; In Sook Woo; Yun Hwa Jung; Jae Ho Byeon; Chan Kwon Park; Tae Jung Kim; Hyo Rim Kim
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

Review 4.  Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.

Authors:  Yi Shao; Dian-Sheng Zhong
Journal:  Int J Clin Oncol       Date:  2017-11-07       Impact factor: 3.402

Review 5.  Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  José M Porcel; Chi Chiu Leung; Marcos I Restrepo; Kazuhisa Takahashi; Pyng Lee
Journal:  Respirology       Date:  2013-04       Impact factor: 6.424

6.  Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.

Authors:  Morena Fasano; Carminia Maria Della Corte; Federica Papaccio; Fortunato Ciardiello; Floriana Morgillo
Journal:  J Thorac Oncol       Date:  2015-08       Impact factor: 15.609

Review 7.  Treatment options for patients with large cell neuroendocrine carcinoma of the lung.

Authors:  Akira Iyoda; Takashi Makino; Satoshi Koezuka; Hajime Otsuka; Yoshinobu Hata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-10

8.  Histological transformation of non-small cell lung cancer: Clinical analysis of nine cases.

Authors:  Cai-Bao Jin; Ling Yang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

9.  Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature.

Authors:  Yasuhiro Sakai; Takashi Yamasaki; Yoshito Kusakabe; Daisuke Kasai; Yoshikazu Kotani; Yoshihiro Nishimura; Tomoo Itoh
Journal:  Multidiscip Respir Med       Date:  2013-07-18

10.  Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an EGFR Mutation: An Autopsy Case Report.

Authors:  Rika Moriya; Satoshi Hokari; Satoshi Shibata; Takeshi Koizumi; Takafumi Tetsuka; Kazuhiko Ito; Hideki Hashidate; Hiroki Tsukada
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.